Leaders in Research
Physician-scientists at NewYork-Presbyterian’s Pediatric Heart Transplant Program have a long history of leading pivotal studies that are instrumental in changing treatment guidelines. As leaders in research, we often adopt novel treatments earlier than other centers—ultimately bringing our patients unprecedented access to safe and effective care. This is evident by doctors at other institutions routinely referring patients to our program to take advantage of treatments not readily available elsewhere.
NewYork-Presbyterian Morgan Stanley plays a leadership role in the Pediatric Heart Transplant Society, which consists of 61 institutions across the globe, and is responsible for a significant proportion of multi-institutional research studies related to pediatric heart transplantation today. We were one of the first centers in the United States to implant a Jarvik 2015 ventricular assist device into a toddler as part of the National Institutes of Health (NIH)-sponsored PumpKIN clinical trial, and we play a prominent role in NIH, Department of Defense, and industry-sponsored multicenter studies on cardiomyopathy, novel immunosuppression regimens, and anti-heart failure medications.
More top pediatric specialists than any other hospital in the country
NewYork-Presbyterian has more top pediatric doctors than any other hospital in the United States and we are proud to have one of the most experienced pediatric heart transplant programs in the country. Our multidisciplinary team approach has set the standard of care for children with end-stage heart failure. This team includes pediatric heart transplant surgeons, cardiologists, nurse practitioners, pharmacists, psychiatrists, child life specialists, social workers, and physical and occupational therapists working together to customize the best care for each child. Our physicians and surgeons are innovators in the field, collaborating to develop and refine techniques that speed recovery for children while achieving high survival rates with few complications. Our dedicated Program provides seamless, state-of-the-art care for children with cardiomyopathy and complex congenital heart disease, whether or not transplantation is necessary.
Our Approach to Care
Family-centered individualized care
It can be difficult for families taking care of sick children to comprehend all of the details of a complicated diagnosis and treatment plan. Because we believe that family knowledge and involvement are critical to successful outcomes, we partner with you every step of the way to develop a comprehensive therapeutic plan to address all your child’s needs. When you bring your child to NewYork-Presbyterian Morgan Stanley, you will benefit from family-centered, individualized care for your child with a proven team of trusted experts.
Consultations are available at NewYork-Presbyterian Morgan Stanley as well as offsite outpatient pediatric practices that may be closer to your home. You may even be able to have your evaluation or get a second opinion remotely, through our telehealth platform.